Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) headquartered in Watertown, will host a conference call for the investment community to discuss the 3Q20 financial results on 4th August 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.enanta.com
Earnings Expectation
Enanta Pharmaceuticals, Inc. is reporting third quarter earnings results on Tuesday 4th August 2020, after market close. The consensus estimates from Thomson Reuters are loss of $ 0.84 per share. For the full year, analysts predict revenues of $ 138.40 million, while looking forward to loss of $ 1.36 per share.
Enanta Pharmaceuticals, Inc., a biotechnology company, focuses on the research and development of small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, primary biliary cholangitis, and hepatitis B virus. Enanta Pharmaceuticals, Inc.
